Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study have?
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study has 66 citations in the OpenAlex counts ScholarIQ stores.
When was Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study published?
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study has 2021 year in the ScholarIQ index.
What is the open-access status of Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study?
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study has gold oa status in the ScholarIQ index.
What is the DOI of Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study?
The DOI for Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study is on the source record.
What is the PMID of Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study?
The PMID for Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study is on the source record.
What is the OpenAlex record for Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study?
The OpenAlex for Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study is on the source record.